Growth Metrics

Novavax (NVAX) Treasury Shares (2016 - 2025)

Novavax has reported Treasury Shares over the past 16 years, most recently at $103.0 million for Q4 2025.

  • Quarterly results put Treasury Shares at $103.0 million for Q4 2025, up 7.48% from a year ago — trailing twelve months through Dec 2025 was $103.0 million (up 7.48% YoY), and the annual figure for FY2025 was $103.0 million, up 7.48%.
  • Treasury Shares for Q4 2025 was $2.4 million at Novavax, up from $2.3 million in the prior quarter.
  • Over the last five years, Treasury Shares for NVAX hit a ceiling of $2.4 million in Q4 2025 and a floor of $261193.0 in Q1 2024.
  • Median Treasury Shares over the past 5 years was $1.2 million (2021), compared with a mean of $1.3 million.
  • Biggest five-year swings in Treasury Shares: skyrocketed 1689.42% in 2021 and later grew 1.77% in 2023.
  • Novavax's Treasury Shares stood at $85.1 million in 2021, then grew by 6.53% to $90.7 million in 2022, then increased by 1.77% to $92.3 million in 2023, then increased by 3.89% to $95.9 million in 2024, then increased by 7.48% to $103.0 million in 2025.
  • The last three reported values for Treasury Shares were $103.0 million (Q4 2025), $102.7 million (Q3 2025), and $102.5 million (Q2 2025) per Business Quant data.